반응 #747579

반응 방정식

N-methylmorpholine-N-oxide

tert-butyl (3S,5S,6S,8S)-6-hydroxy-8-(hydroxymethyl)-3-((1-(3-methoxypropyl)-1H-indazol-6-yl)methyl)-2,9-dimethyldecan-5-ylcarbamate

→

tert-butyl (1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-((1-(3-methoxypropyl)-1H-indazol-6-yl)methyl)-4-methylpentylcarbamate

수율 37.0%

용매

CH2Cl2

CH2Cl2

반응 조건

후처리

1. 1
   기타at rt
2. 2
   workup.STIRRINGThe mixture was stirred overnight
3. 3
   여과filtered through a pad of silica gel
4. 4
   세척The filtrate was washed with water and brine
5. 5
   기타evaporated
6. 6
   기타purified by flash chromatography on silica gel

실험 절차

To a stirred solution of N-methylmorpholine-N-oxide (270 mg, 2 mmol) in dry CH2Cl2 (10 mL) was added activated 4 Å molecular sieves (500 mg) at rt under N2. After stirring for 2 h this mixture was added to a mixture of tetrapropylammonium perruthenate (22 mg, 0.062 mmol) and tert-butyl (3S,5S,6S,8S)-6-hydroxy-8-(hydroxymethyl)-3-((1-(3-methoxypropyl)-1H-indazol-6-yl)methyl)-2,9-dimethyldecan-5-ylcarbamate (0.33 g, 0.62 mmol) in dry CH2Cl2 (20 mL). The mixture was stirred overnight and filtered through a pad of silica gel. The filtrate was washed with water and brine, evaporated, and purified by flash chromatography on silica gel to afford tert-butyl (1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-((1-(3-methoxypropyl)-1H-indazol-6-yl)methyl)-4-methylpentylcarbamate (120 mg, 37%). 1H NMR (400 MHz, CDCl3): δ7.93 (s, 1H), 7.60 (d, J=8.4 Hz, 1H), 7.20 (s, 1H), 6.98 (d, J=8.0 Hz, 1H), 4.46-4.38 (m, 4H), 3.89 (m, 1H), 3.29 (s, 6H), 2.86 (m, 1H), 2.58-2.52 (m, 2H), 2.18-2.2.08 (m, 5H), 1.70 (m, 2H), 1.47 (s, 9H), 1.04 (d, J=6.4 Hz, 3H), 1.00 (d, J=6.8 Hz, 3H), 0.92 (d, J=6.4 Hz, 3H), 0.89 (d, J=6.4 Hz, 3H); MS: 530 (M++1)

출처